VSEE
VSee Health, Inc.
Medical - Healthcare Information Services
Market Cap$3M
5Y Perf.-98.0%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
VSEE vs TDOC vs AMWL vs HIMS
Revenue, margins, valuation, and 5-year total return — side by side.
TDOC
Teladoc Health, Inc.
Medical - Healthcare Information Services
Market Cap$1.26B
5Y Perf.-38.0%
AMWL
American Well Corporation
Medical - Healthcare Information Services
Market Cap$129M
5Y Perf.+22.6%
HIMS
Hims & Hers Health, Inc.
Medical - Equipment & Services
Market Cap$6.63B
5Y Perf.+40.0%
VSEE vs TDOC vs AMWL vs HIMS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | VSEE | TDOC | AMWL | HIMS |
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Equipment & Services |
| Market Cap | $3M | $1.26B | $129M | $6.63B |
| Revenue (TTM) | $15M | $2.51B | $182M | $2.35B |
| Net Income (TTM) | $-12M | $-171M | $-88M | $128M |
| Gross Margin | 54.6% | 65.6% | 38.7% | 69.7% |
| Operating Margin | -69.3% | -7.6% | -50.6% | 4.6% |
| Forward P/E | — | — | — | 51.5x |
| Total Debt | $10M | $1.04B | $5M | $1.12B |
| Cash & Equiv. | $326K | $781M | $182M | $229M |
VSEE vs TDOC vs AMWL vs HIMS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
VSEE
TDOC
AMWL
HIMS
| Stock | Jun 24 | May 26 | Return |
|---|---|---|---|
| VSee Health, Inc. (VSEE) | 100 | 2.0 | -98.0% |
| Teladoc Health, Inc. (TDOC) | 100 | 62.0 | -38.0% |
| American Well Corpo… (AMWL) | 100 | 122.6 | +22.6% |
| Hims & Hers Health,… (HIMS) | 100 | 140.0 | +40.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VSEE vs TDOC vs AMWL vs HIMS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: VSEE and HIMS are tied at the top with 2 categories each — the right choice depends on your priorities. Hims & Hers Health, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. TDOC and AMWL also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
VSEE
VSee Health, Inc.
The Income Pick
VSEE has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- beta 1.40
- Rev growth 80.7%, EPS growth -13.9%, 3Y rev CAGR 12.4%
- 80.7% revenue growth vs AMWL's -2.0%
- Beta 1.40 vs HIMS's 2.40
Best for: income & stability and growth exposure
TDOC
Teladoc Health, Inc.
The Value Play
TDOC is the clearest fit if your priority is value.
- Better valuation composite
Best for: value
AMWL
American Well Corporation
The Defensive Pick
AMWL is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.47, Low D/E 1.8%, current ratio 3.37x
- Beta 1.47, current ratio 3.37x
- +14.3% vs VSEE's -85.9%
Best for: sleep-well-at-night and defensive
HIMS
Hims & Hers Health, Inc.
The Long-Run Compounder
HIMS is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 161.9% 10Y total return vs TDOC's -41.1%
- 5.5% margin vs VSEE's -85.8%
- 6.0% ROA vs VSEE's -66.7%, ROIC 10.7% vs -17.5%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | VSEE | 80.7% revenue growth vs AMWL's -2.0% |
| Value | TDOC | Better valuation composite |
| Quality / Margins | HIMS | 5.5% margin vs VSEE's -85.8% |
| Stability / Safety | VSEE | Beta 1.40 vs HIMS's 2.40 |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | AMWL | +14.3% vs VSEE's -85.9% |
| Efficiency (ROA) | HIMS | 6.0% ROA vs VSEE's -66.7%, ROIC 10.7% vs -17.5% |
VSEE vs TDOC vs AMWL vs HIMS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
FY 2025
Segment breakdown not available.
VSEE vs TDOC vs AMWL vs HIMS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLHIMSLAGGINGVSEE
Who Leads Where
HIMS leads in 2 of 6 categories
TDOC leads 1 • AMWL leads 1 • VSEE leads 0 • 1 tied
Explore the data ↓VSEEVSee Health, Inc.
0leads
AMWLAmerican Well Corpora…
1leads
TDOCTeladoc Health, Inc.
1leads
HIMSHims & Hers Health, I…
2leads
6 Total Categories
CATEGORYLEADERvs TDOCvs AMWLMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
HIMS4/6
Valuation MetricsMultiples, price ratios, and targets
TDOC3/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
HIMS4/6
Risk & VolatilityBeta, volatility, and downside exposure
AMWL2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
HIMS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TDOC is the larger business by revenue, generating $2.5B annually — 172.8x VSEE's $15M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to VSEE's -85.8%. On growth, HIMS holds the edge at +28.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $15M | $2.5B | $182M | $2.3B |
| EBITDAEarnings before interest/tax | -$7M | $42M | -$59M | $164M |
| Net IncomeAfter-tax profit | -$12M | -$171M | -$88M | $128M |
| Free Cash FlowCash after capex | -$5M | $251M | -$42M | $73M |
| Gross MarginGross profit ÷ Revenue | +54.6% | +65.6% | +38.7% | +69.7% |
| Operating MarginEBIT ÷ Revenue | -69.3% | -7.6% | -50.6% | +4.6% |
| Net MarginNet income ÷ Revenue | -85.8% | -6.8% | -48.2% | +5.5% |
| FCF MarginFCF ÷ Revenue | -31.1% | +10.0% | -22.9% | +3.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | -2.5% | -100.0% | +28.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.5% | +32.1% | +44.5% | -27.3% |
HIMS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
TDOC leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, TDOC's 15.1x EV/EBITDA is more attractive than HIMS's 42.7x.
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| Market CapShares × price | $3M | $1.3B | $129M | $6.6B |
| Enterprise ValueMkt cap + debt − cash | $12M | $1.5B | -$48M | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | -6.11x | -1.30x | 50.32x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 51.51x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 15.13x | — | 42.68x |
| Price / SalesMarket cap ÷ Revenue | 0.28x | 0.50x | 0.52x | 2.82x |
| Price / BookPrice ÷ Book value/share | — | 0.89x | 0.50x | 12.25x |
| Price / FCFMarket cap ÷ FCF | — | 4.40x | — | 89.61x |
TDOC leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
Evenly matched — AMWL and HIMS each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-33 for AMWL. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), TDOC scores 6/9 vs HIMS's 4/9, reflecting solid financial health.
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -12.4% | -33.5% | +23.7% |
| ROA (TTM)Return on assets | -66.7% | -5.9% | -25.1% | +6.0% |
| ROICReturn on invested capital | -17.5% | -11.5% | -95.1% | +10.7% |
| ROCEReturn on capital employed | -63.3% | -10.0% | -36.6% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 0.75x | 0.02x | 2.07x |
| Net DebtTotal debt minus cash | $9M | $259M | -$178M | $892M |
| Cash & Equiv.Liquid assets | $326,115 | $781M | $182M | $229M |
| Total DebtShort + long-term debt | $10M | $1.0B | $5M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | -4.76x | -8.76x | -239.18x | — |
Evenly matched — AMWL and HIMS each lead in 4 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $100 for VSEE. Over the past 12 months, AMWL leads with a +14.3% total return vs VSEE's -85.9%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs VSEE's -78.5% — a key indicator of consistent wealth creation.
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -59.0% | -1.3% | +59.8% | -23.2% |
| 1-Year ReturnPast 12 months | -85.9% | +1.5% | +14.3% | -51.0% |
| 3-Year ReturnCumulative with dividends | -99.0% | -73.3% | -80.7% | +116.6% |
| 5-Year ReturnCumulative with dividends | -99.0% | -95.4% | -97.2% | +137.6% |
| 10-Year ReturnCumulative with dividends | -99.0% | -41.1% | -98.3% | +161.9% |
| CAGR (3Y)Annualised 3-year return | -78.5% | -35.6% | -42.2% | +29.4% |
HIMS leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
AMWL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VSEE is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than HIMS's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMWL currently trades 84.7% from its 52-week high vs VSEE's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 1.91x | 1.31x | 2.40x |
| 52-Week HighHighest price in past year | $2.52 | $9.77 | $9.15 | $70.43 |
| 52-Week LowLowest price in past year | $0.17 | $4.40 | $3.71 | $13.74 |
| % of 52W HighCurrent price vs 52-week peak | +6.9% | +71.2% | +84.7% | +36.4% |
| RSI (14)Momentum oscillator 0–100 | 27.7 | 74.1 | 67.1 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 560K | 5.5M | 59K | 34.9M |
AMWL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: TDOC as "Hold", HIMS as "Hold". Consensus price targets imply 15.6% upside for HIMS (target: $30) vs 8.9% for TDOC (target: $8).
| Metric | VSEEVSee Health, Inc. | TDOCTeladoc Health, I… | AMWLAmerican Well Cor… | HIMSHims & Hers Healt… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | — | Hold |
| Price TargetConsensus 12-month target | — | $7.58 | — | $29.67 |
| # AnalystsCovering analysts | — | 42 | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.0% | +1.4% |
Insufficient data to determine a leader in this category.
Key Takeaway
HIMS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). TDOC leads in 1 (Valuation Metrics). 1 tied.
Best OverallHims & Hers Health, Inc. (HIMS)Leads 2 of 6 categories
Loading custom metrics...
VSEE vs TDOC vs AMWL vs HIMS: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is VSEE or TDOC or AMWL or HIMS a better buy right now?
For growth investors, VSee Health, Inc.
(VSEE) is the stronger pick with 80. 7% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 50. 3x trailing P/E (51. 5x forward), making it the more compelling value choice. Analysts rate Teladoc Health, Inc. (TDOC) a "Hold" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — VSEE or TDOC or AMWL or HIMS?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -99. 0% for VSee Health, Inc. (VSEE). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus VSEE's -99. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — VSEE or TDOC or AMWL or HIMS?
By beta (market sensitivity over 5 years), American Well Corporation (AMWL) is the lower-risk stock at 1.
31β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 84% more volatile than AMWL relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — VSEE or TDOC or AMWL or HIMS?
By revenue growth (latest reported year), VSee Health, Inc.
(VSEE) is pulling ahead at 80. 7% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -1386. 8% for VSee Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — VSEE or TDOC or AMWL or HIMS?
Hims & Hers Health, Inc.
(HIMS) is the more profitable company, earning 5. 5% net margin versus -553. 7% for VSee Health, Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIMS leads at 5. 2% versus -596. 4% for VSEE. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is VSEE or TDOC or AMWL or HIMS more undervalued right now?
Analyst consensus price targets imply the most upside for HIMS: 15.
6% to $29. 67.
07Which pays a better dividend — VSEE or TDOC or AMWL or HIMS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is VSEE or TDOC or AMWL or HIMS better for a retirement portfolio?
For long-horizon retirement investors, American Well Corporation (AMWL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMWL: -98. 3%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between VSEE and TDOC and AMWL and HIMS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VSEE is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock; AMWL is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(VSEE: 18.7% · TDOC: -2.5%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.